Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism

Mol Psychiatry. 2006 Dec;11(12):1073-84. doi: 10.1038/sj.mp.4001883. Epub 2006 Aug 29.

Abstract

Autism has a strong genetic background with a higher frequency of affected males suggesting involvement of X-linked genes and possibly also other factors causing the unbalanced sex ratio in the etiology of the disorder. We have identified two missense mutations in the ribosomal protein gene RPL10 located in Xq28 in two independent families with autism. We have obtained evidence that the amino-acid substitutions L206M and H213Q at the C-terminal end of RPL10 confer hypomorphism with respect to the regulation of the translation process while keeping the basic translation functions intact. This suggests the contribution of a novel, possibly modulating aberrant cellular function operative in autism. Previously, we detected high expression of RPL10 by RNA in situ hybridization in mouse hippocampus, a constituent of the brain limbic system known to be afflicted in autism. Based on these findings, we present a model for autistic disorder where a change in translational function is suggested to impact on those cognitive functions that are mediated through the limbic system.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Autistic Disorder / genetics*
  • Autistic Disorder / metabolism*
  • Autistic Disorder / pathology
  • Chromosomes, Human, X
  • Female
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Male
  • Mental Retardation, X-Linked / genetics*
  • Mental Retardation, X-Linked / metabolism
  • Mice
  • Models, Neurological
  • Mutation, Missense*
  • Pedigree
  • Protein Biosynthesis / genetics*
  • Ribosomal Protein L10
  • Ribosomal Proteins / genetics*
  • Ribosomal Proteins / metabolism

Substances

  • RPL10 protein, human
  • Ribosomal Proteins
  • Rpl10 protein, mouse